Skip to content

Application of Multimodal Radiomics in Breast Disease

Application of Multimodal Radiomics in Breast Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106666
Enrollment
Unknown
Registered
2025-07-28
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Disease

Interventions

Gold Standard:Pathological results of breast diseases
Index test:Retrospectively analyze the imaging features such as X - ray, ultrasound, and MRI of the selected cases. Select corresponding cases for AI - assisted diagnosis, screen radiomics features, a

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients with Breast Disorders Who Possess Complete Clinical and Pathological Documentation; 2.Patients Underwent Pre-Treatment Mammography Screening Prior to Any Therapeutic Intervention; 3.Patients Were De Novo Cases with No Prior History of Breast Cancer Treatment, Including Surgery, Chemotherapy, Radiotherapy, or Endocrine Therapy; 4.No Prior History of Clinical Interventions for Breast-Related Conditions, Including Benign Breast Diseases (e.g., Fibroadenoma, Mastitis) or Previous Breast Biopsy Procedures.

Exclusion criteria

Exclusion criteria: 1. Lack of any image results of mammary X-ray examination CC or MLO; 2. The quality of breast X-ray examination does not meet the diagnostic and measurement standards; 3. No surgery or puncture was performed in our hospital to obtain pathological results; 4. Patients undergo clinical intervention related to breast disease.

Design outcomes

Primary

MeasureTime frame
Image features;Sensitivity;specificity;accuracy;Positive predictive value;Negative predictive value;

Countries

China

Contacts

Public ContactShi Chunying

The First Affiliated Hospital of Harbin Medical University

ssccyyfsx@sina.com+86 451 8555 5564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026